BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Hemispherx Biopharma Inc. 

One Penn Center
1617 JFK Boulevard
Philadelphia  Pennsylvania  19103  U.S.A.
Phone: 215-988-0080 Fax: 215-988-1739


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Hemispherx Biopharma (HEB) Announces The Completion Of The Newly Upgraded Alferon Facility: Commercial Production Of Alferon Is In The Final Stage Integrating Continuous Flow Manufacturing Technology 3/2/2015 7:14:42 AM
Hemispherx Biopharma (HEB): Institute Of Medicine, The Health Arm Of The US National Academy of Sciences Reframes Chronic Fatigue Syndrome (CFS) As A "Systemic Exertion Intolerance Disease" (SEID) 2/23/2015 7:31:14 AM
Hemispherx Biopharma (HEB) And USAMRIID To Present New Discoveries Concerning The Efficacy Of Ampligen Against The Ebola Virus At Upcoming International Symposium On Filoviruses 2/12/2015 7:35:56 AM
Hemispherx Biopharma (HEB) Posts USAMRIID Ebola Study Concluding Ampligen Produced 100% Survival Rate In Rodents With 100% Mortality In Placebo 2/9/2015 7:37:25 AM
Hemispherx Biopharma (HEB): US Army Scientists (USAMRIID) Find Ampligen® Produces 100% Survival Rate In Ebola Virus Rodent Study 2/2/2015 10:33:28 AM
Hemispherx Biopharma (HEB): US Army Scientists (USAMRIID) Find Ampligen(R) Produces 100% Survival Rate In Ebola Virus Rodent Study 2/2/2015 7:56:13 AM
Hemispherx Biopharma (HEB) Release: USAMRIID Reports Genetic Changes In Ebola Virus May Impede Potential Treatments 1/26/2015 7:49:23 AM
Hemispherx Biopharma (HEB) Awarded $770,852 by Federal Judge 1/15/2015 7:09:42 AM
Hemispherx Biopharma (HEB) Release: Low Natural Killer (NK) Activity Observed Across The Chronic Fatigue Syndrome (CFS) Disease Spectrum 1/12/2015 7:07:11 AM
Arrowhead Issues Diligence And Valuation Report On Hemispherx Biopharma (HEB) 1/9/2015 7:45:35 AM
12345678910...